- Home
- VTGN vs AMTX Comparison
VTGN vs AMTX Comparison
Compare VTGN & AMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTGN
- AMTX
- Stock Information
- Founded
- VTGN 1998
- AMTX 2005
- Country
- VTGN United States
- AMTX United States
- Employees
- VTGN N/A
- AMTX N/A
- Industry
- VTGN Biotechnology: Pharmaceutical Preparations
- AMTX Major Chemicals
- Sector
- VTGN Health Care
- AMTX Industrials
- Exchange
- VTGN Nasdaq
- AMTX Nasdaq
- Market Cap
- VTGN 130.1M
- AMTX 150.1M
- IPO Year
- VTGN N/A
- AMTX N/A
- Fundamental
- Price
- VTGN $3.97
- AMTX $2.10
- Analyst Decision
- VTGN
- AMTX Strong Buy
- Analyst Count
- VTGN 0
- AMTX 3
- Target Price
- VTGN N/A
- AMTX $17.33
- AVG Volume (30 Days)
- VTGN 488.7K
- AMTX 1.4M
- Earning Date
- VTGN 11-07-2025
- AMTX 11-06-2025
- Dividend Yield
- VTGN N/A
- AMTX N/A
- EPS Growth
- VTGN N/A
- AMTX N/A
- EPS
- VTGN N/A
- AMTX N/A
- Revenue
- VTGN $646,000.00
- AMTX $201,323,000.00
- Revenue This Year
- VTGN $9.14
- AMTX $6.44
- Revenue Next Year
- VTGN $467.87
- AMTX $114.64
- P/E Ratio
- VTGN N/A
- AMTX N/A
- Revenue Growth
- VTGN N/A
- AMTX N/A
- 52 Week Low
- VTGN $1.90
- AMTX $1.22
- 52 Week High
- VTGN $4.65
- AMTX $4.73
- Technical
- Relative Strength Index (RSI)
- VTGN 49.15
- AMTX 39.19
- Support Level
- VTGN $3.69
- AMTX $1.61
- Resistance Level
- VTGN $4.65
- AMTX $2.15
- Average True Range (ATR)
- VTGN 0.29
- AMTX 0.21
- MACD
- VTGN -0.03
- AMTX -0.07
- Stochastic Oscillator
- VTGN 22.40
- AMTX 30.29
About VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.
About AMTX Aemetis Inc. (DE)
Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries. It owns and operates an approximately 65 million gallon per year ethanol production facility located in Keyes, California. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. It operates in the reportable geographic segments of North America and India.